Literature DB >> 8570819

Surveillance for fetal alcohol syndrome in Colorado.

L A Miller1, T Shaikh, C Stanton, A Montgomery, R Rickard, S Keefer, R Hoffman.   

Abstract

The authors performed surveillance for fetal alcohol syndrome with an existing birth defects registry. Fetal alcohol syndrome cases were identified from multiple sources using passive surveillance and from two selected medical sites using enhanced surveillance. Between May 1992 and March 1994, a total of 173 cases were identified, and the medical records of the cases were reviewed to determine whether the cases met a surveillance case definition for fetal alcohol syndrome. Of these cases, 37 (21 percent) met either definite (28) or probable (9) criteria for fetal alcohol syndrome, 76 met possible criteria (44 percent), and 60 (35 percent) were defined as not fetal alcohol syndrome. Enhanced surveillance had the highest sensitivity for definite or probable cases, 31 of 37 (84 percent), followed by hospital discharge data, 14 of 37 (38 percent). The authors also compared birth certificate information for 22 definite or probable cases in children born between 1989 and 1992 to birth certificate information for all Colorado births for that period. The proportion of mothers of children with fetal alcohol syndrome was statistically significantly greater (as determined by exact binomial 95 percent confidence limits) than the proportion of all mothers for the following characteristics: black race (0.23 versus 0.05), unmarried (0.55 versus 0.22), not employed during pregnancy (0.86 versus 0.43), and started prenatal care in the third trimester (0.18 versus 0.04). Surveillance for fetal alcohol syndrome can be accomplished with an existing registry system in combination with additional case finding and verification activities. Through followup investigation of reported cases, data can be gathered on the mothers of children with fetal alcohol syndrome. These data could be used to target fetal alcohol syndrome prevention programs.

Entities:  

Mesh:

Year:  1995        PMID: 8570819      PMCID: PMC1381808     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  15 in total

Review 1.  A revised conservative estimate of the incidence of FAS and its economic impact.

Authors:  E L Abel; R J Sokol
Journal:  Alcohol Clin Exp Res       Date:  1991-06       Impact factor: 3.455

2.  Fetal alcohol syndrome. Experience with 41 patients.

Authors:  J W Hanson; K L Jones; D W Smith
Journal:  JAMA       Date:  1976-04-05       Impact factor: 56.272

3.  Guidelines for use of terminology describing the impact of prenatal alcohol on the offspring.

Authors:  R J Sokol; S K Clarren
Journal:  Alcohol Clin Exp Res       Date:  1989-08       Impact factor: 3.455

4.  Evaluation of the hospital discharge diagnoses index and the birth certificate as sources of information on birth defects.

Authors:  A C Hexter; J A Harris; P Roeper; L A Croen; P Krueger; D Gant
Journal:  Public Health Rep       Date:  1990 May-Jun       Impact factor: 2.792

Review 5.  The fetal alcohol syndrome.

Authors:  S K Clarren; D W Smith
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

6.  Failure to recognize fetal alcohol syndrome in newborn infants.

Authors:  B B Little; L M Snell; C R Rosenfeld; L C Gilstrap; N F Gant
Journal:  Am J Dis Child       Date:  1990-10

7.  Characteristics of parental response to fetal alcohol syndrome.

Authors:  P J Wilson; R V Scott; F H Briggs; S E Ince; B A Quinton; V E Headings
Journal:  Birth Defects Orig Artic Ser       Date:  1984

8.  Fetal alcohol syndrome in families.

Authors:  E L Abel
Journal:  Neurotoxicol Teratol       Date:  1988 Jan-Feb       Impact factor: 3.763

9.  Fetal alcohol syndrome in adolescents and adults.

Authors:  A P Streissguth; J M Aase; S K Clarren; S P Randels; R A LaDue; D F Smith
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

10.  The influence of socioeconomic factors on the occurrence of fetal alcohol syndrome.

Authors:  N Bingol; C Schuster; M Fuchs; S Iosub; G Turner; R K Stone; D S Gromisch
Journal:  Adv Alcohol Subst Abuse       Date:  1987
View more
  7 in total

1.  Screening for pregnancy and contraceptive use among women admitted to a Denver detoxification center.

Authors:  S Shah; R Hoffman; R Shinault; S LaPoint
Journal:  Public Health Rep       Date:  1998 Jul-Aug       Impact factor: 2.792

Review 2.  Identifying maternal risk factors associated with Fetal Alcohol Spectrum Disorders: a systematic review.

Authors:  Larissa Horta Esper; Erikson Felipe Furtado
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-28       Impact factor: 4.785

3.  Systematic literature review on which maternal alcohol behaviours are related to fetal alcohol spectrum disorders (FASD).

Authors:  Sylvia Roozen; Gjalt-Jorn Ygram Peters; Gerjo Kok; David Townend; Jan Nijhuis; Ger Koek; Leopold Curfs
Journal:  BMJ Open       Date:  2018-12-19       Impact factor: 2.692

Review 4.  Fetal alcohol-spectrum disorders: identifying at-risk mothers.

Authors:  Annika C Montag
Journal:  Int J Womens Health       Date:  2016-07-21

5.  Manitoba mothers and fetal alcohol spectrum disorders study (MBMomsFASD): protocol for a population-based cohort study using linked administrative data.

Authors:  Deepa Singal; Marni Brownell; Ana Hanlon-Dearman; Dan Chateau; Sally Longstaffe; Leslie L Roos
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

Review 6.  The causal web of foetal alcohol spectrum disorders: a review and causal diagram.

Authors:  Cheryl McQuire; R Daniel; L Hurt; A Kemp; S Paranjothy
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-01-16       Impact factor: 4.785

7.  Predictive value of indicators for identifying child maltreatment and intimate partner violence in coded electronic health records: a systematic review and meta-analysis.

Authors:  Shabeer Syed; Rachel Ashwick; Marco Schlosser; Arturo Gonzalez-Izquierdo; Leah Li; Ruth Gilbert
Journal:  Arch Dis Child       Date:  2020-08-11       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.